Skip to main content

Table 2 Summary of tau interacting HNRNPs and select disease associated RNA binding proteins from human studies

From: Tau interactome and RNA binding proteins in neurodegenerative diseases

RBP

Number of Studies

pTau Interactor

APEX tagged

Interacts with Mutant Tau

Present in NFT

Altered in GVD Neurons

Altered in NFT Neurons

Interacts with Mutant Tau

HNRNPK

4

Yes

No

Yes

Yes

No (Increased)

No

Yes

HNRNPA1

4

Yes

Yes

Yes

Yes

No (Increased)

No

Yes

HNRNPA2B1

4

Yes

No

Yes

Yes

No (Increased)

No

Yes

HNRNPA3

4

No

No

Yes

Yes

No

No (Decreased)

Yes

HNRNPA0

3

No

No

Yes

No

No

No (Decreased)

Yes

HNRNPC

3

No

No

Yes

Yes

No

No

Yes

HNRNPD

3

No

No

Yes

Yes

No

Yes (Decreased)

Yes

HNRNPM

3

No

No

Yes

Yes

No (Decreased)

Yes (Decreased)

Yes

HNRNPR

3

No

No

Yes

Yes

No

Yes (Decreased)

Yes

HNRNPU

3

No

No

Yes

Yes

Yes (Decreased)

Yes (Decreased)

Yes

PTBP1

4

No

No

Yes

No

No

No

Yes

FUS

3

No

No

Yes

Yes

No

Yes (Decreased)

Yes

SFPQ

3

No

No

Yes

Yes

No

No (Increased)

Yes

G3BP1

3

No

No

Yes

No

No

NA

Yes

NONO

3

No

No

Yes

Yes

No

NA

Yes

PABPC1

3

No

Yes

Yes

Yes

No

NA

Yes

TARDBP

1

No

No

Yes

Yes

Yes (Decreased)

Yes (Decreased)

Yes

TIA1

N.D

N.D

N.D

N.D

N.D

N.D

N.D

N.D

  1. Table shows the number of human tau interactome studies each RNA binding protein (RBP) has been identified in, if there is an interaction between the RBP and phosphorylated tau (pTau; [30]), if the RBP interacts with tau in a human cell culture model using APEX [105], if it is present in neurofibrillary tangles (NFTs; [30], if protein levels are altered in neurons containing granulovacuolar degeneration or NFTs (Yes/No indicates whether it passed FDR < 0.05 whilst ‘Increased/Decreased’ denote a greater than 10% change in estimated protein expression, N.D. denotes protein not detected; [52]).